BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35090496)

  • 1. Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.
    Salami R; Salami M; Mafi A; Vakili O; Asemi Z
    Cell Commun Signal; 2022 Jan; 20(1):13. PubMed ID: 35090496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Glioblastoma CircularRNAome.
    Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
    Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Hypoxia in Glioblastoma Invasion.
    Monteiro AR; Hill R; Pilkington GJ; Madureira PA
    Cells; 2017 Nov; 6(4):. PubMed ID: 29165393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy.
    Westhoff MA; Karpel-Massler G; Brühl O; Enzenmüller S; La Ferla-Brühl K; Siegelin MD; Nonnenmacher L; Debatin KM
    Mol Cell Ther; 2014; 2():32. PubMed ID: 26056598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme.
    Mencke P; Hanss Z; Boussaad I; Sugier PE; Elbaz A; Krüger R
    Front Neurol; 2020; 11():898. PubMed ID: 32973662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment.
    Rahban M; Joushi S; Bashiri H; Saso L; Sheibani V
    Front Chem; 2023; 11():1325214. PubMed ID: 38264122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
    Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M
    Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated cell death in glioma: promising targets for natural small-molecule compounds.
    Han M; Li S; Fan H; An J; Peng C; Peng F
    Front Oncol; 2024; 14():1273841. PubMed ID: 38304870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma.
    Singh RR; Mondal I; Janjua T; Popat A; Kulshreshtha R
    Bioact Mater; 2024 Mar; 33():396-423. PubMed ID: 38059120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments.
    Qiu J; Qian D; Jiang Y; Meng L; Huang L
    Front Oncol; 2023; 13():1288077. PubMed ID: 37941557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Non-Coding RNAs in TGF-β Signalling in Glioma.
    Shree B; Sharma V
    Brain Sci; 2023 Sep; 13(10):. PubMed ID: 37891744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circRNA_0084043 promoting tumorigenesis in glioma through miR-577 sponging.
    Qian J; Chen C; Zhao C; Xu X; Xu Y; Zhang Y; Qian C
    Heliyon; 2023 Sep; 9(9):e19219. PubMed ID: 37662721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review.
    Nafe R; Hattingen E
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradural Intramedullary Spinal Cord Glioblastoma: A Case Report.
    Shrestha P; Eineichner T; Wilson B; Lam NS
    Cureus; 2023 Aug; 15(8):e43580. PubMed ID: 37593069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.
    Rahmati A; Mafi A; Vakili O; Soleymani F; Alishahi Z; Yahyazadeh S; Gholinezhad Y; Rezaee M; Johnston TP; Sahebkar A
    Ann Hematol; 2024 May; 103(5):1455-1482. PubMed ID: 37526673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
    Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
    Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircCCDC66: Emerging roles and potential clinical values in malignant tumors.
    Wang X; Zhang C; Song H; Yuan J; Zhang L; He J
    Front Oncol; 2022; 12():1061007. PubMed ID: 36698408
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.